Activities of erythropoietin on tumors: An immunological perspective
✍ Scribed by Pietro Ghezzi; Manuela Mengozzi
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 113 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
There is a growing interest in the non‐erythropoietic, tissue‐protective and restorative actions of erythropoietin (EPO). While studies in this field have indicated that EPO can ameliorate chemotherapy‐induced peripheral neuropathy and cardiotoxicity, the issue whether EPO can positively or negatively affect cancer patients is a hot one. In this debate, many activities of EPO are being considered, including tissue/neuroprotection, angiogenesis, anti‐inflammatory activity, growth promotion, and inhibition of apoptosis. However, few studies have explored the interactions of EPO with the immune system. A study in this issue of the European Journal of Immunology by Katz et al. adds one new piece to the puzzle by showing that EPO can stimulate B cell‐mediated immunity.
See accompanying article: http://dx.doi.org/10.1002/eji.200637025
📜 SIMILAR VOLUMES
The immunological activities of an IgG antibody bound on Fc receptors, such as protein A and protein G, pre-coated on a glassy carbon electrode surface have been studied. In order to discriminate the effects of molecular orientation and the conformation retention of the antibody on a protein sublaye
After injection of isografted mammary tumor M M 2 sensitized with rabbit antiserum, resistance was induced in C3HIHe mice after repeated challenges with MM2. The serum taken from these mice was found to be cytotoxic against M M 2 cells. The serum also inhibited the outgrowth of transplant of primary